News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

First U.S. Patient Treated Following FDA Approval of Cook Medical’s First-of-Its-Kind Zilver® PTX® Drug-Eluting Peripheral Stent


12/19/2012 9:32:29 AM

BLOOMINGTON, Ind.--(BUSINESS WIRE)- Just weeks after the Food and Drug Administration (FDA) approved Cook Medical’s Zilver® PTX® Drug-Eluting Peripheral Stent, OhioHealth Riverside Methodist Hospital in Columbus, Ohio, has treated the first patient with the device as part of Cook’s U.S. commercial launch.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES